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ABSTRACT
Background: The first step in the diagnosis of lung
cancer is for individuals in the general population to
recognise respiratory alarm symptoms (RAS).
Knowledge is sparse about RAS and factors associated
with experiencing RAS in the general population. This
study aimed to estimate the prevalence of RAS in the
general population, and to analyse possible associations
between lifestyle factors and experiencing RAS.
Methods: A web-based survey comprising 100 000
individuals randomly selected from the Danish Civil
Registration System. Items regarding experience of RAS
(prolonged coughing, shortness of breath, coughing up
blood and prolonged hoarseness) and self-reported
lifestyle factors (smoking status, alcohol intake and
body mass index) were included in the analysis.
Results: A total of 49 706 individuals completed the
questionnaire. 16 per cent reported at least one RAS.
Prolonged coughing (8.4%) and shortness of breath
(8%) were most prevalent, while coughing up blood
was least prevalent (0.1%). More men than women
reported RAS (p<0.001). Odds of reporting RAS
increased with age (Ptrend<0.001). In men and women,
former and current smoking was associated with
reporting at least one RAS (former smoking:
ORmen=1.42, 95% CI 1.39 to 1.56; ORwomen=1.25, 95%
CI 1.15 to 1.36; current smoking: ORmen=2.58, 95% CI
2.35 to 2.83; ORwomen=2.45, 95% CI 2.25 to 2.68).
Individuals who were underweight or obese were
significantly more likely to report at least one RAS. Odds
of reporting at least one RAS increased with increasing
alcohol intake for both genders (Ptrend<0.001).
Conclusions: RAS are common in the general
population. Men experience more symptoms than
women, and prevalence increases with age. Being a
former or current smoker and being underweight or
obese are positively associated with experiencing RAS.
The likelihood of experiencing RAS increases with
increasing alcohol intake. Future research should
investigate healthcare seeking for RAS among
individuals with different lifestyles.
INTRODUCTION
More than 90% of the population have
experienced at least one symptom within the
preceding week1 and 15% have experienced
an alarm symptom within the last year,2 sub-
stantiating the premise that symptoms are
frequently experienced in the general popu-
lation.1 Most symptoms are caused by benign
conditions, while others are signs of serious
disorders such as cancer. Recognition of
symptoms is a vital part of lung cancer diag-
nosis,3 as most individuals with lung cancer
present with symptoms at some point4 5 and
because long patient intervals have been asso-
ciated with poor survival rates among patients
with lung cancer.6 Thus some countries have
introduced cancer referral guidelines in
order to improve the diagnostic interval, that
is, to shorten the interval between the ﬁrst
symptom experience and diagnosis.7–9 The
lung cancer guidelines deﬁne a number of
respiratory alarm symptoms (RAS) that
should raise suspicion about lung cancer
when encountered in general practice.10 11
However, the ﬁrst step in the diagnosis of
lung cancer is for individuals in the general
population to recognise their symptoms.
Current knowledge about RAS is mainly
based on retrospective studies conducted
among selected groups of patients already
diagnosed with lung cancer,3 12 or on
KEY MESSAGES
▸ Respiratory alarm symptoms and factors affect-
ing the experience of these in the general popu-
lation are important to understand and improve
lung cancer diagnosis.
▸ Respiratory alarm symptoms are common in the
general population, with 16% having experi-
enced at least one respiratory alarm symptom
within the preceding 4 weeks. Men report more
respiratory alarm symptoms than women, and
symptom reporting increases with age.
▸ Current smokers and underweight or obese indi-
viduals are more likely to report respiratory
alarm symptoms. This might be useful in plan-
ning future population-based awareness
campaigns.
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presentation of RAS in general practice.13 Little is known
about the prevalence of RAS in the general population.
Research has illustrated that symptom experiences are
regarded as subjective interpretations of sensations and
bodily changes, and that the interpretation process is
affected by a complex mixture of multiple factors,
including lifestyle factors, health perceptions and social
network.14 15 Thus, the frequency of RAS may vary
among subgroups in the general population.16 Smoking
is a strong risk factor for developing lung cancer,17 and
it is likely that smokers experience more RAS than non-
smokers.18 Other lifestyle factors such as alcohol intake
and body mass index (BMI) can also affect the experi-
ence of RAS. Still, knowledge is sparse regarding RAS in
the general population and how lifestyle factors inﬂu-
ence the occurrence of RAS.
Awareness of lung cancer symptoms and risk factors is
sparse.19 In order to improve awareness and healthcare
seeking with cancer alarm symptoms in the general popu-
lation, awareness campaigns have been launched.20 21
These awareness campaigns have focused on signs and
symptoms of cancer, and have encouraged the general
population to contact general practice when experien-
cing cancer alarm symptoms. The campaigns have had a
wide focus on different symptoms and different cancer
forms, which might have inﬂuenced the effect.22 23
Therefore, more targeted campaigns have been sug-
gested, emphasising the need for an enhanced under-
standing of the symptom experiences in different groups.
The objectives of this study were to obtain prevalence
estimates of RAS in the general population and to analyse
possible associations between lifestyle factors and RAS.
METHODS
Study design and population
This study was a nationwide cohort study of 100 000
adults aged 20 years or older, randomly selected from
the general population. The sample was drawn from the
Danish Civil Registration System (CRS), in which all
Danish citizens are registered with a unique personal
identiﬁcation number. The CRS contains information
about every Danish resident’s date of birth, gender,
migration, etc.24 Each individual received a postal letter
explaining the purpose of the study. A unique 12-digit
login for a secure webpage was included in the letter,
which provided access to a comprehensive web-based
questionnaire. Participants without access to a computer,
tablet or smartphone, were offered the opportunity to
complete the survey as a telephone interview. A
reminder letter was sent to the non-respondents 2 weeks
after the invitational letter, and after an additional
2 weeks, the non-respondents were contacted by tele-
phone and encouraged to participate.25
The questionnaire
A comprehensive questionnaire concerning the experi-
ence of 44 predeﬁned speciﬁc and non-speciﬁc cancer
alarm symptoms, as well as general and frequent symp-
toms, was developed. The questionnaire was based on
standard rating scales, previously validated question-
naires and ad hoc items. The methodological framework
for developing, pilot testing and ﬁeld testing the ques-
tionnaire is described in detail elsewhere.25 Alarm symp-
toms for several different cancers (lung, gastrointestinal,
urological and gynaecological) were selected based on a
literature review that included national and international
cancer referral guidelines.3 5 10 11 In total, four RAS
indicative of lung cancer form the basis of this paper:
prolonged coughing, shortness of breath, coughing up
blood and prolonged hoarseness.11
Respondents were asked whether they had experi-
enced one or more RAS within the preceding 4 weeks.
The wording of the question regarding symptoms was:
‘Have you experienced any of the following bodily sensa-
tions, symptoms, or discomforts within the past
4 weeks?’. An item concerning when the symptom(s)
occurred for the ﬁrst time was also included. The
response categories were: ‘Less than 1 month ago’, ‘1–
3 months ago’, ‘3–6 months ago’ or ‘more than
6 months ago’. Questions regarding current smoking
status, average alcohol intake, weight and height were
also asked.
Statistical analyses
In the cancer referral guidelines, coughing and hoarse-
ness are deﬁned as RAS when they are prolonged, that
is, last for more than 4–6 and 3–4 weeks, respectively.9
To approach concordance with these deﬁnitions, only
respondents who had experienced the symptom for the
ﬁrst time more than 1 month ago were considered to
have experienced prolonged coughing and prolonged
hoarseness.
Covariates considered in the statistical analyses were
gender, age, smoking status, alcohol intake and BMI.
The respondents were divided into the following age
groups: 20–39, 40–59, 60–79 and ≥80 years. Smoking
status was categorised as current, former and never
smoker. Alcohol intake was categorised in units per
week: 0, 1–7, 8–21 and ≥22 units/week. BMI was calcu-
lated from height and weight, and categorised according
to WHO guidelines as follows: underweight (BMI
<18.5), normal weight (BMI 18.5–24.9), overweight
(BMI 25–29.9) and obese (BMI ≥30).20
Prevalence estimates were calculated for reporting at
least one RAS and for each individual RAS. One
symptom was deﬁned as having experienced at least
one, but possibly more than one, of the four RAS. CIs
for all prevalence estimates were calculated using the
binomial distribution. Differences between reporting of
RAS were tested for each covariate using either the χ2
test or Fisher’s exact test, as appropriate.
Logistic regression models were used to test for inter-
action between gender and each covariate with regard to
at least one symptom, prolonged coughing, shortness of
breath or prolonged hoarseness, respectively. The tests
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were made with Bonferroni adjustment to account for
multiple testing. A test for interaction was not made for
coughing up blood, because of the small number of
respondents that reported this symptom.
To evaluate collinearity between lifestyle factors, cor-
relation coefﬁcients were calculated with Spearman’s
rank correlation. Multivariate logistic regression models
were used to analyse the association between each cov-
ariate and reporting of at least one RAS, and each indi-
vidual RAS. Owing to interactions, the analyses were
stratiﬁed with respect to gender. Adjustments were made
for possible confounders: age, smoking status, alcohol
intake and BMI.
Linear trends in the reporting of RAS were tested with
logistic regression models for age and alcohol intake.
For alcohol intake, the test for trend only included
respondents who drank more than 0 units/week.
All statistical tests were subjected to a signiﬁcance
threshold of 0.05. Data analyses were conducted using
Stata IC 13 software.
RESULTS
Of the 100 000 randomly selected individuals, 4747
(4.7%) were not eligible because they had died, could
not be reached due to unknown address, were suffering
from severe illnesses (including dementia), had lan-
guage problems, or had moved abroad. Of the 95 253
(95.3%) eligible individuals, 49 706 completed the ques-
tionnaire, yielding an overall response rate of 52.2%
(ﬁgure 1). Some 53.2% of respondents were women,
compared to 48.6% of non-respondents. The median
age of respondents was 52 years (IQR 40–64). In com-
parison, median age of non-respondents was 50 years
(IQR 36–66).
Table 1 lists the prevalence estimates for reporting at
least one RAS and each individual RAS during the pre-
ceding 4 weeks. A total of 7870 (16%) respondents
reported at least one RAS. Prolonged coughing (8.5%)
and shortness of breath (8%) were most common, pro-
longed hoarseness (3.4%) was less common and cough-
ing up blood (0.1%) was rare.
In general, more men than women reported RAS
(p<0.05). However, the difference between genders was
not signiﬁcant for prolonged hoarseness. The preva-
lence estimates for symptom experiences differed signiﬁ-
cantly with respect to age group (p<0.001), smoking
status (p<0.001), alcohol intake (p<0.001) and BMI
(p<0.001), although not signiﬁcantly for coughing up
blood (table 1).
Tables 2 and 3 depict the ORs of associations between
age, smoking status, alcohol intake, BMI, and reporting
of RAS for men and women, respectively. Since low cor-
relations were observed between lifestyle factors, they
were all included in the same multivariate logistic regres-
sion models.
Age
Odds of reporting at least one RAS, prolonged cough-
ing, shortness of breath or prolonged hoarseness
increased with increasing age (Ptrend<0.001) among men
(table 2) and among women (table 3).
Smoking status
Regarding both genders, odds of reporting at least one
RAS were signiﬁcantly higher for former smokers
(ORmen=1.42, 95% CI 1.30 to 1.56; ORwomen=1.25, 95%
CI 1.15 to 1.36) and current smokers (ORmen=2.58, 95%
CI 2.35 to 2.83; ORwomen=2.45, 95% CI 2.25 to 2.68)
Figure 1 Study cohort.
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Table 1 Prevalence of respiratory alarm symptoms by gender, age, smoking status, alcohol intake and body mass index
Total
study
sample
At least one respiratory alarm
symptom Prolonged coughing Shortness of breath Coughing up blood Prolonged hoarseness
N n
Per
cent 95% CI p Value* N
Per
cent 95% CI p Value* n
Per
cent 95% CI p Value* n
Per
cent 95% CI p Value† N
Per
cent 95% CI p Value*
Total 49 706 7 870 16.0 15.7 to 16.3 4 180 8.5 8.2 to 8.7 3 960 8.0 7.8 to 8.3 62 0.1 0.1 to 0.2 1694 3.4 3.3 to 3.6
Gender <0.001 <0.001 0.043 0.001 0.296
Men 23 240 3 978 16.9 16.4 to 17.4 2 095 9.1 8.7 to 9.5 1 912 8.3 8.0 to 8.7 42 0.2 0.1 to 0.2 813 3.5 3.3 to 3.8
Women 26 466 3 892 15.2 14.7 to 15.6 2 085 8.0 7.6 to 8.3 2 048 7.8 7.5 to 8.1 20 0.1 0.05 to 0.1 881 3.4 3.1 to 2.6
Age (years) <0.001 <0.001 <0.001 0.842 <0.001
20–39 12 251 1 643 13.5 12.9 to 14.2 813 6.7 6.3 to 7.2 880 7.3 6.8 to 7.7 18 0.2 0.1 to 0.2 303 2.5 2.2 to 2.8
40–59 20 305 2 794 13.9 13.4 to 14.3 1 452 7.2 6.8 to 7.6 1 423 7.1 6.7 to 7.4 23 0.1 0.1 to 0.2 519 2.6 2.4 to 2.8
60–79 15 748 3 044 19.5 18.9 to 20.2 1 696 10.9 10.4 to 11.4 1 457 9.4 8.9 to 9.8 23 0.1 0.1 to 0.2 750 4.8 4.5 to 5.2
>80 1402 389 28.8 26.4 to 31.3 219 16.2 14.3 to 18.3 200 14.8 12.9 to 16.8 1 0.1 0.001 to 0.4 122 9.0 7.5 to 10.7
Smoking
status‡
<0.001 <0.001 <0.001 0.092 <0.001
Never 21 895 2 480 11.3 10.9 to 11.8 1 262 5.8 5.5 to 6.1 1 224 5.6 5.3 to 5.9 19 0.1 0.1 to 0.1 567 2.6 2.4 to 2.8
Former 15 529 2488 16.0 15.4 to 16.6 1 097 7.1 6.7 to 7.5 1 387 8.9 8.5 to 9.4 20 0.1 0.1 to 0.2 617 4.0 3.7 to 4.3
Current 10 300 2 519 24.5 23.6 to 25.3 1 635 15.9 15.2 to 16.6 1 131 11.0 10.4 to 11.6 18 0.2 0.1 to 0.3 430 4.2 3.8 to 4.6
Alcohol intake
(units/week)‡
<0.001 <0.001 <0.001 0.404 <0.001
0 3668 813 22.2 20.8 to 23.5 409 11.2 10.1 to 12.2 489 13.3 12.2 to 14.5 7 0.2 0.1 to 0.4 167 4.6 3.9 to 5.3
1–7 31 607 4 436 14.0 13.7 to 14.4 2 290 7.3 7.0 to 7.5 2 258 7.1 6.9 to 7.4 34 0.1 0.1 to 0.2 993 3.1 3.0 to 3.3
8–21 10 708 1 828 17.1 16.4 to 17.8 1 043 9.7 9.2 to 10.3 820 7.7 7.2 to 8.2 13 0.1 0.1 to 0.2 375 3.5 3.2 to 3.9
≥22 1729 409 23.7 21.7 to 25.7 251 14.5 12.9 to 16.3 174 10.1 8.7 to 11.6 3 0.2 0.04 to 0.5 79 4.6 3.6 to 5.7
Body mass
index‡
<0.001 <0.001 <0.001 0.481 <0.001
Underweight
(<18.5)
756 154 20.4 17.6 to 23.4 88 11.6 9.4 to 14.1 79 10.5 8.4 to 12.9 1 0.1 0.003 to 0.7 43 5.7 4.1 to 7.6
Normal
(18.5–24.9)
23 168 3214 13.9 13.4 to 14.3 1 731 7.5 7.0 to 7.8 1 494 6.5 6.1 to 2.8 25 0.1 0.07 to 0.2 734 3.2 2.9 to 3.4
Overweight
(25–29.9)
16 668 2644 15.9 15.3 to 16.4 1 409 8.5 8.0 to 8.9 1 297 7.8 7.4 to 8.2 19 0.1 0.07 to 0.2 556 3.3 3.1 to 3.6
Obese
(≥30)
6990 1435 20.5 19.6 to 21.5 737 10.5 9.8 to 11.3 855 12.2 11.5 to 13.0 12 0.2 0.01 to 0.3 273 3.9 3.5 to 4.4
*Tested for difference between groups with χ2 test, statistical significance p<0.05.
†Tested for difference between groups with Fisher’s exact test, statistical significance p<0.05.
‡Total numbers for each group may not add to full sample due to missing data.
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Table 2 Associations between lifestyle factors and experience of respiratory alarm symptoms for men
At least one respiratory alarm
symptom Prolonged coughing Shortness of breath Coughing up blood Prolonged hoarseness
OR
Adjusted
OR* 95% CI Ptrend† OR
Adjusted
OR* 95% CI Ptrend† OR
Adjusted
OR* 95% CI Ptrend† OR
Adjusted
OR* 95% CI Ptrend† OR
Adjusted
OR* 95% CI Ptrend†
Age (years) <0.001 <0.001 <0.001 0.222 <0.001
20–39 1 1 1 1 1 1 1 1 1 1
40–59 1.03 0.97 0.88 to 1.08 0.97 0.97 0.85 to 1.11 1.07 0.95 0.83 to 1.09 0.64 0.44 0.19 to 0.99 1.00 0.98 0.78 to 1.23
60–79 1.54 1.40 1.27 to 1.55 1.46 1.49 1.30 to 1.70 1.37 1.13 0.99 to 1.30 0.60 0.56 0.25 to 1.28 2.16 1.97 1.59 to 2.44
>80 2.33 2.32 1.89 to 2.84 2.47 3.02 2.36 to 3.85 2.04 2.21 1.95 to 2.51 0.59 0.64 0.08 to 5.06 3.64 3.36 2.38 to 4.73
Smoking status
Never 1 1 1 1 1 1 1 1 1 1
Former 1.68 1.42 1.30 to 1.56 1.36 1.11 0.98 to 1.26 1.91 1.71 1.51 to 1.94 1.21 1.35 0.58 to 3.13 2.01 1.62 1.36 to 1.94
Current 2.70 2.58 2.35 to 2.83 3.28 3.09 2.75 to 3.47 2.25 2.13 1.85 to 2.45 2.12 2.19 1.00 to 4.78 1.65 1.54 1.27 to 1.88
Alcohol intake
(units/week)
<0.001‡ <0.001‡ 0.269‡ 0.955‡ 0.823
0 1 1 1 1 1 1 1 1 1 1
1–7 0.49 0.58 0.50 to 0.67 0.54 0.65 0.54 to 0.79 0.45 0.53 0.44 to 0.64 0.55 0.70 0.21 to 2.35 0.62 0.66 0.50 to 0.87
8–21 0.61 0.62 0.54 to 0.73 0.69 0.75 0.62 to 0.91 0.51 0.52 0.43 to 0.63 0.56 0.62 0.17 to 2.26 0.64 0.59 0.44 to 0.80
≥22 0.88 0.79 0.66 to 0.96 1.05 0.98 0.78 to 1.24 0.68 0.62 0.49 to 0.79 0.78 0.82 0.16 to 4.08 0.83 0.72 0.50 to 1.04
Body mass
index
Underweight
(<18.5)
2.27 2.01 1.31 to 3.07 2.37 2.01 1.22 to 3.32 1.52 1.30 0.69 to 2.46 – – – 2.95 2.80 1.47 to 5.33
Normal
(18.5–24.9)
1 1 1 1 1 1 1 1 1 1
Overweight
(25–29.9)
1.11 1.11 1.03 to 1.21 1.01 1.05 0.94 to 1.16 1.26 1.25 1.11 to 1.40 0.91 1.01 0.48 to 2.11 0.98 0.91 0.77 to 1.07
Obese (≥30) 1.57 1.60 1.44 to 1.77 1.29 1.38 1.21 to 1.59 2.16 2.13 1.86 to 2.43 1.67 1.88 0.81 to 4.36 1.13 1.04 0.84 to 1.29
Bold indicates statistical significance at 5% level.
*Adjusted for: age, smoking status, alcohol intake and body mass index.
†Statistically significant Ptest for trend<0.05.
‡Only tested for those who drink more than 0 units/week.
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Table 3 Associations between lifestyle factors and experience of respiratory alarm symptoms for women
At least one respiratory alarm
symptom Prolonged coughing Shortness of breath Coughing up blood Prolonged hoarseness
OR
Adjusted
OR* 95% CI Ptrend† OR
Adjusted
OR* 95% CI Ptrend† OR
Adjusted
OR* 95% CI Ptrend† OR
Adjusted
OR* 95% CI Ptrend† OR
Adjusted
OR* 95% CI Ptrend†
Age (years) <0.001 <0.001 <0.001 0.529 <0.001
20–39 1 1 1 1 1 1 1 1 1 1
40–59 1.02 0.93 0.85 to 1.03 1.20 1.12 0.98 to 1.28 0.89 0.81 0.72 to 0.91 1.20 1.06 0.30 to 3.70 1.05 1.01 0.83 to 1.23
60–79 1.55 1.52 1.38 to 1.36 1.96 2.00 1.75 to 2.28 1.27 1.24 1.09 to 1.41 1.71 1.77 0.51 to 6.08 1.80 1.77 1.46 to 2.16
>80 2.82 2.56 2.25 to 2.67 2.91 3.25 2.52 to 4.18 2.39 2.30 1.81 to 2.94 – – – 4.10 4.19 3.06 to 5.74
Smoking
status
Never 1 1 1 1 1 1 1 1 1 1
Former 1.32 1.25 1.15 to 1.36 1.13 1.02 0.90 to 1.15 1.45 1.44 1.29 to 1.61 1.84 1.90 0.68 to 5.32 1.20 1.11 0.94 to 1.31
Current 2.39 2.45 2.25 to 2.68 2.89 3.25 2.52 to 4.18 1.96 2.07 1.84 to 2.33 1.40 1.39 0.40 to 4.81 1.66 1.70 1.43 to 2.02
Alcohol intake
(units/week)
<0.001‡ <0.001‡ 0.468‡ 0.032
0 1 1 1 1 1 1 1 1 1 1
1–7 0.55 0.61 0.55 to 0.68 0.62 0.68 0.59 to 0.78 0.44 0.52 0.46 to 0.60 0.49 0.38 0.12 to 1.21 0.65 0.71 0.57 to 0.88
8–21 0.79 0.74 0.65 to 0.84 0.99 0.92 0.77 to 1.09 0.54 0.53 0.45 to 0.63 0.48 0.44 0.08 to 1.81 0.86 0.81 0.62 to 1.05
≥22 1.45 1.26 0.94 to 1.68 2.02 1.67 1.19 to 2.35 0.71 0.65 0.42 to 0.99 – – – 1.40 1.25 0.72 to 2.15
Body mass
index
Underweight
(<18.5)
1.54 1.33 1.07 to 1.64 1.61 1.34 1.02 to 1.76 1.73 1.49 1.14 to 1.93 2.17 2.07 0.26 to 16.43 1.71 1.48 1.02 to 2.15
Normal
(18.5–24.9)
1 1 1 1 1 1 1 1 1 1
Overweight
(25–29.9)
1.18 1.17 1.07 to 1.64 1.24 1.23 1.10 to 1.37 1.17 1.15 1.03 to 1.29 0.98 0.90 0.30 to 2.65 1.11 1.07 0.91 to 1.26
Obese (≥30) 1.60 1.66 1.51 to 1.84 1.60 1.71 1.50 to 1.95 1.90 1.90 1.67 to 2.15 1.14 1.00 0.27 to 3.71 1.33 1.35 1.11 to 1.64
Bold indicates statistical significance at 5% level.
*Adjusted for: age, smoking status, alcohol intake and body mass index.
†Test for trend: Statistically significant Ptest for trend<0.05.
‡Only tested for those who drink more than 0 units/week.
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than for never smokers. Current smoking was signiﬁ-
cantly associated with reporting prolonged coughing,
shortness of breath and prolonged hoarseness for both
genders (tables 2 and 3), and, among men, with cough-
ing up blood (table 2).
Alcohol intake
Overall, individuals reporting an alcohol intake of 1–7
or 8–21 units/week had signiﬁcantly lower odds of
reporting RAS than those who reported drinking
0 units/week. Among both men and women who
reported alcohol intake >0 units/week, we observed a
trend of increased reporting of at least one RAS with
increasing alcohol intake (Ptrend<0.001). This was also
the case for reporting prolonged coughing in both men
and women (Ptrend<0.001), and, among women, for pro-
longed hoarseness (Ptrend=0.032; tables 2 and 3).
Body mass index
In men and women, odds of reporting at least one RAS
were signiﬁcantly higher for individuals who were under-
weight (ORmen=2.01, 95% CI 1.31 to 3.07;
ORwomen=1.33, 95% CI 1.07 to 1.64) or obese
(ORmen=1.60, 95% CI 1.44 to 1.77; ORwomen=1.66, 95%
CI 1.51 to 1.84) compared to individuals at normal
weight (tables 2 and 3). Being underweight or obese was
also signiﬁcantly associated with reporting prolonged
coughing among both men and women, and, among
women, for shortness of breath and prolonged hoarse-
ness (tables 2 and 3).
DISCUSSION
Summary and main findings
This study shows that RAS are common in the general
population. Sixteen per cent of respondents reported at
least one symptom. The most prevalent symptoms were
prolonged coughing (8.5%) and shortness of breath
(8%), while prolonged hoarseness (3.4%) and coughing
up blood (0.1%) were least frequent. Men more frequently
reported RAS, and odds of reporting RAS increased with
age for both men and women. Lifestyle factors were signiﬁ-
cantly associated with experiencing RAS. Former and
current smokers were more likely to report RAS than
never smokers. Being underweight or obese was positively
associated with reporting RAS. Among individuals who
reported alcohol intake, odds of reporting RAS increased
with increasing alcohol intake; however, individuals report-
ing an alcohol intake were less likely to report RAS than
individuals with no alcohol intake.
Strength and limitations
A major strength of this study is the large study sample
of 100 000 randomly selected Danish individuals. The
response rate (52.2%) is similar to or exceeds that of
previous population-based studies.1 18 26 Although more
of the respondents were women and the respondents
were slightly older than the non-respondents, the
respondents were fairly representative of the general
adult Danish population. However, we were unable to
eliminate the possibility that the respondents could
differ from the non-respondents regarding other para-
meters, which might include a risk of overestimating or
underestimating the prevalence.
Willingness to respond to the questionnaire might
depend on the presence of symptoms.27 28 If individuals
with many RAS were more willing to answer, the preva-
lence estimates might have been overestimated.
However, individuals with many RAS might not have the
surplus of energy to respond to a comprehensive ques-
tionnaire, which would counterbalance the
aforementioned.
The fact that the questionnaire was web-based could
have prevented some individuals, for example, the
elderly, from participating in the survey.29 We sought to
minimise this possibility by offering individuals without a
computer, smartphone, or tablet, the opportunity to
conduct the survey as a telephone interview.
Nevertheless, a lower response rate was still found in the
oldest age group, which might indicate that the tele-
phone interview did not completely compensate for the
possible selection. The lower response rate might result
in bias, because older respondents might be in better
health than older non-respondents. Thus, the preva-
lence of RAS among the oldest age group might be even
higher than estimated in the present study.
Information about symptom experiences was self-
reported, and respondents were asked to recall symptom
experiences within the 4 weeks preceding completion of
the questionnaire. The time of recall was chosen
because it seems reasonable to assume that individuals
can recall symptom experiences fairly accurately within
that timespan.30 31 However, recall bias cannot be elimi-
nated. Some respondents may misplace older symptoms
in the speciﬁc time period, providing an overestimation
of prevalence.32 However, others may recall fewer symp-
toms due to, for example, memory decay, providing an
underestimation of the prevalence.33
Reporting of lifestyle factors might be biased due to a
general tendency to underreport smoking status, alcohol
intake and weight, and a tendency to over-report
height.34–36 However, web-based questionnaires have
been suggested to enhance the perception of privacy
among respondents, increasing the reliability of answers
regarding sensitive issues, such as lifestyle factors.37 38
Although avoidance of misclassiﬁcation might not be
possible, the questionnaire was comprehensive and
considered a broad range of different symptom experi-
ences and topics. This makes it unlikely that, for
example, the experience of RAS addressed initially
in the questionnaire has affected answers regarding life-
style factors addressed later in the questionnaire.
A possible misclassiﬁcation would, therefore, be non-
differentiated.39
The analyses were adjusted for age and each lifestyle
factor.17 40 41 Comorbidity was considered a potential
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confounder, but was not included in the model because
we found that it was more likely to be a mediator of the
association between lifestyle factors and experience of
RAS.
Discussion of results and comparison with the existing
literature
Few studies have estimated the prevalence of respiratory
symptoms in the general population.2 18 26 42 McAteer
et al18 found the prevalence of coughing to be 17.8%,
compared with 8.5% in the present study, while
Svendsen et al2 observed a prevalence of coughing of
6.5%. One explanation for these differences might be
the different time interval for reporting symptom experi-
ences. McAteer et al18 did not restrict the duration of
coughing, while the present study only included cough-
ing that lasted longer than 4 weeks, and Svendsen et al2
included individuals who experienced coughing for
more than 6 weeks. Prevalence estimates for shortness of
breath and coughing up blood in the McAteer study
were comparable to those in the present study.18 Petrie
et al42 and Whitaker et al26 observed higher prevalence
of symptom experiences. Petrie et al42 published a preva-
lence of coughing of 28.3% and a prevalence of short-
ness of breath of 13.2%; however, they collected data
during ﬂu and cold season. Whitaker et al26 reported a
prevalence of persistent coughing of 20.3%, but used a
broader deﬁnition of persistent coughing than the
present study, and also included symptom experiences
within the last 3 months.
In contrast to the ﬁndings of the present study,
McAteer et al18 observed no gender difference in the
prevalence estimates of coughing and shortness of
breath. Furthermore, older age groups reported signiﬁ-
cantly lower odds of coughing and shortness of breath,18
while the present study demonstrated higher odds of
reporting RAS in the oldest age groups. The age span
differed between McAteer et al,18 who only included
individuals aged 60 years or younger, and the present
study, which included all individuals aged 20 years or
older. However, this difference does not explain the dif-
ferent ﬁndings in the two studies.
The present study shows that RAS are common. RAS
are deﬁned as warning signs of lung cancer, but may be
signs of more benign conditions, as well. Distinguishing
between benign conditions and serious diseases such as
cancer is difﬁcult, and poses a challenge for physicians
as well as the general population. Experiencing and
interpreting symptoms is a complex process that involves
several parameters.14 Qualitative studies have mentioned
that individuals in the general population often consider
age, former experienced symptoms and lifestyle factors
in their interpretation of symptoms.16 43
In the present study, current and former smokers were
more likely to report RAS than never smokers. The
results were expected, considering that smoking is a risk
factor for several respiratory diseases, thus likely leading
to symptoms.17 41 Studies have shown that current
smokers have a tendency to normalise their symp-
toms.44 45 If that is the case, then the odds of current
smokers experiencing RAS might be underestimated in
the present study.
Individuals drinking 1–7 and 8–21 units/week were
less likely to report RAS than individuals who never
drink alcohol. One possible explanation for this is that
the never drinkers represent a group characterised by
morbidity resulting in many symptoms and inability to
drink alcohol. Another, possibly more plausible explan-
ation, is that the never drinkers may represent a group
that has made a deliberate choice of healthy living,46
and are thus more aware of symptom experiences and
report more symptoms when asked during completion
of a questionnaire. This theory is not supported in the
current literature, but could be investigated in future
research.
Underweight and obese individuals were more likely
to report RAS than individuals with normal weight. One
possible explanation, at least for shortness of breath, is
that underweight and obese individuals experience
more of a strain on their bodies than individuals at
normal weight. Underweight or obese individuals might
also be more aware of their bodies, resulting in remem-
bering and reporting more symptom experiences when
asked during completion of a questionnaire. These
hypotheses have not been tested in previous studies, but
could be addressed in future studies.
Conclusion and implications
This population-based study showed that 16% of the
general population experienced at least one RAS within
the preceding 4 weeks and that lifestyle factors inﬂu-
enced the experience of RAS.
The ﬁrst step in the diagnosis of lung cancer is for
individuals with RAS to recognise their symptoms.
Knowledge about the prevalence of RAS in the general
population and in subgroups with different lifestyles
might be useful in the understanding of the diagnostic
pathway of lung cancer, and may help policymakers to
develop targeted campaigns. Although many people
experience RAS, few are diagnosed with lung cancer.
Nevertheless, it is necessary to seek healthcare in order
for lung cancer to be diagnosed. Smoking, older age
and being underweight or obese are positively associated
with experiencing RAS. Whether these factors also inﬂu-
ence healthcare-seeking when RAS are experienced is
unknown. Future research should investigate healthcare-
seeking behaviour among subgroups with different
lifestyles.
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